fashion -WSS

fashion

author：fashion 2025-09-28 23:11:52 - browse：5449

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： 'Vaccine

leisure time

entertainment

WSS

How medical schools plan to diversify without affirmative action

What to make of Biden’s latest efforts on cancer research

CDC advisory group OKs chikungunya vaccine

STAT Madness 2024: Meet the contenders

Generate Biomedicines machine learning biotech raises $273M

Generate Biomedicines machine learning biotech raises $273M

explore

fashion

focus

Medical records are filled with copy

Change Healthcare cyberattack shows risk of industry consolidation

Walensky prepares to leave CDC — and Congress — behind

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Guidelines to prevent youth baseball injuries need more muscle

Popular nasal decongestant doesn't actually relieve congestion

How to save PrEP access — and even expand it

Private equity could exacerbate cardiology's overuse problem, experts fear

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Walmart eyes Medicare Advantage provider ChenMed

explore

What to make of Biden’s latest efforts on cancer research

5 ways to address the shortage of health care workers

Diverse clinical trials: Why aren’t we there yet?

FDA approves updated Covid vaccines

Pig kidney works a record two months in donated body

Are embryos people? Reproductive medicine's future depends on the answer

leisure time

knowledge

entertainment

focus